| PD-1 signaling | R-HSA-389948 | 7.62 |
| GPVI-mediated activation cascade | R-HSA-114604 | 7.18 |
| Toll Like Receptor 4 (TLR4) Cascade | R-HSA-166016 | 6.11 |
| Signaling by the B Cell Receptor (BCR) | R-HSA-983705 | 4.62 |
| Cell-Cell communication | R-HSA-1500931 | 5.87 |
| Regulation of IFNA signaling | R-HSA-912694 | 8.34 |
| GAB1 signalosome | R-HSA-180292 | 6.31 |
| Developmental Biology | R-HSA-1266738 | 3.48 |
| Toll Like Receptor 3 (TLR3) Cascade | R-HSA-168164 | 6.47 |
| IRS-mediated signalling | R-HSA-112399 | 4.87 |
| Platelet homeostasis | R-HSA-418346 | 6.68 |
| Signal regulatory protein (SIRP) family interactions | R-HSA-391160 | 8.98 |
| RAF-independent MAPK1/3 activation | R-HSA-112409 | 8.46 |
| Spry regulation of FGF signaling | R-HSA-1295596 | 9.18 |
| Interferon Signaling | R-HSA-913531 | 4.95 |
| Signaling by EGFR | R-HSA-177929 | 4.59 |
| Nuclear signaling by ERBB4 | R-HSA-1251985 | 7.7 |
| Prolactin receptor signaling | R-HSA-1170546 | 9.08 |
| MAPK1 (ERK2) activation | R-HSA-112411 | 9.81 |
| PI-3K cascade:FGFR3 | R-HSA-5654710 | 6.37 |
| Regulation of IFNG signaling | R-HSA-877312 | 9.18 |
| FRS-mediated FGFR4 signaling | R-HSA-5654712 | 5.14 |
| Tie2 Signaling | R-HSA-210993 | 8.81 |
| PECAM1 interactions | R-HSA-210990 | 9.4 |
| Signaling by ERBB2 | R-HSA-1227986 | 4.66 |
| Netrin mediated repulsion signals | R-HSA-418886 | 9.66 |
| PI3K/AKT activation | R-HSA-198203 | 6.32 |
| Immune System | R-HSA-168256 | 2.37 |
| PI3K events in ERBB2 signaling | R-HSA-1963642 | 6.37 |
| Downstream signal transduction | R-HSA-186763 | 4.65 |
| Role of LAT2/NTAL/LAB on calcium mobilization | R-HSA-2730905 | 4.95 |
| CTLA4 inhibitory signaling | R-HSA-389513 | 8.52 |
| FRS-mediated FGFR2 signaling | R-HSA-5654700 | 5.14 |
| Interferon gamma signaling | R-HSA-877300 | 5.67 |
| FRS-mediated FGFR3 signaling | R-HSA-5654706 | 5.14 |
| MyD88-independent TLR3/TLR4 cascade | R-HSA-166166 | 6.47 |
| Downstream signaling of activated FGFR3 | R-HSA-5654708 | 4.71 |
| Fc epsilon receptor (FCERI) signaling | R-HSA-2454202 | 4.03 |
| Downstream signaling of activated FGFR4 | R-HSA-5654716 | 4.71 |
| Innate Immune System | R-HSA-168249 | 3.17 |
| SHC-mediated cascade:FGFR4 | R-HSA-5654719 | 8.46 |
| NGF signalling via TRKA from the plasma membrane | R-HSA-187037 | 4.51 |
| Signaling by FGFR2 | R-HSA-5654738 | 4.68 |
| Signaling by FGFR1 | R-HSA-5654736 | 4.69 |
| Negative regulation of FGFR4 signaling | R-HSA-5654733 | 8.03 |
| Negative regulation of FGFR3 signaling | R-HSA-5654732 | 8.12 |
| PI3K Cascade | R-HSA-109704 | 6.68 |
| DAP12 interactions | R-HSA-2172127 | 4.56 |
| Interferon alpha/beta signaling | R-HSA-909733 | 6.04 |
| Axon guidance | R-HSA-422475 | 3.93 |
| Activation of IRF3/IRF7 mediated by TBK1/IKK epsilon | R-HSA-936964 | 8.81 |
| TRIF-mediated TLR3/TLR4 signaling | R-HSA-937061 | 6.47 |
| Signaling by Leptin | R-HSA-2586552 | 5.1 |
| Constitutive Signaling by Aberrant PI3K in Cancer | R-HSA-2219530 | 7.05 |
| IGF1R signaling cascade | R-HSA-2428924 | 4.85 |
| IRS-related events triggered by IGF1R | R-HSA-2428928 | 4.85 |
| Signaling by Insulin receptor | R-HSA-74752 | 4.73 |
| Disease | R-HSA-1643685 | 3.33 |
| Insulin receptor signalling cascade | R-HSA-74751 | 4.85 |
| Downstream signaling of activated FGFR1 | R-HSA-5654687 | 4.71 |
| PI-3K cascade:FGFR4 | R-HSA-5654720 | 6.37 |
| PI-3K cascade:FGFR1 | R-HSA-5654689 | 6.37 |
| Negative regulation of FGFR1 signaling | R-HSA-5654726 | 7.98 |
| Negative regulation of FGFR2 signaling | R-HSA-5654727 | 7.89 |
| Toll-Like Receptors Cascades | R-HSA-168898 | 5.91 |
| Downstream signaling events of B Cell Receptor (BCR) | R-HSA-1168372 | 5.59 |
| PI3K/AKT Signaling in Cancer | R-HSA-2219528 | 6.56 |
| Diseases of signal transduction | R-HSA-5663202 | 4.89 |
| SHC-mediated cascade:FGFR2 | R-HSA-5654699 | 8.28 |
| PI-3K cascade:FGFR2 | R-HSA-5654695 | 6.37 |
| Downstream signaling of activated FGFR2 | R-HSA-5654696 | 4.71 |
| FRS-mediated FGFR1 signaling | R-HSA-5654693 | 5.14 |
| Interleukin-6 signaling | R-HSA-1059683 | 9.52 |
| Signaling by PDGF | R-HSA-186797 | 4.53 |
| Activated TLR4 signalling | R-HSA-166054 | 6.27 |
| Netrin-1 signaling | R-HSA-373752 | 7.59 |
| Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | R-HSA-2404192 | 4.85 |
| Signaling by Interleukins | R-HSA-449147 | 4.71 |
| PI3K events in ERBB4 signaling | R-HSA-1250342 | 6.37 |
| Cell surface interactions at the vascular wall | R-HSA-202733 | 6.32 |
| Cytokine Signaling in Immune system | R-HSA-1280215 | 3.74 |
| Signaling by ERBB4 | R-HSA-1236394 | 4.7 |
| MAPK1/MAPK3 signaling | R-HSA-5684996 | 5.11 |
| Adaptive Immune System | R-HSA-1280218 | 3.19 |
| MAPK family signaling cascades | R-HSA-5683057 | 4.89 |
| PIP3 activates AKT signaling | R-HSA-1257604 | 6.37 |
| Platelet activation, signaling and aggregation | R-HSA-76002 | 5.15 |
| Platelet sensitization by LDL | R-HSA-432142 | 8.89 |
| Costimulation by the CD28 family | R-HSA-388841 | 6.56 |
| Signaling by FGFR4 | R-HSA-5654743 | 4.69 |
| Signaling by FGFR3 | R-HSA-5654741 | 4.69 |
| Signaling by FGFR | R-HSA-190236 | 4.67 |
| Signaling by SCF-KIT | R-HSA-1433557 | 4.73 |
| DAP12 signaling | R-HSA-2424491 | 4.64 |
| Interleukin-3, 5 and GM-CSF signaling | R-HSA-512988 | 4.99 |
| Signalling by NGF | R-HSA-166520 | 4.23 |
| MAPK3 (ERK1) activation | R-HSA-110056 | 9.66 |
| Hemostasis | R-HSA-109582 | 3.98 |
| Signal Transduction | R-HSA-162582 | 1.78 |